1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Furukawa, K. Oda, M. Nakamura, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 93 13583 13588 10.1073/pnas.93.24.13583 8942977 A small engineered protein lacks structural uniqueness by increasing the side-chain conformational entropy. 1996 US Nat.Struct.Biol. NSBIEW 2024 1072-8368 2 309 Comparison of the Free and DNA-Complexed Forms of the DNA-Binding Domain from C-Myb 1995 US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 79 639 Solution Structure of a Specific DNA Complex of the Myb DNA-Binding Domain with Cooperative Recognition Helices 1994 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 89 6428 Solution Structure of a DNA-Binding Unit of Myb: A Helix-Turn-Helix-Related Motif with Conserved Tryptophans Forming a Hydrophobic Core 1992 10.2210/pdb1idz/pdb pdb_00001idz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6521.496 MOUSE C-MYB DNA-BINDING DOMAIN REPEAT 3 P140M, I155L 1 man polymer no no MEVKKTSWTEEEDRILYQAHKRLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKV MEVKKTSWTEEEDRILYQAHKRLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKV A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus Escherichia sample 10090 Mus musculus 562 Escherichia coli PAR2156NCOI PRP3 database_2 pdbx_database_related pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_keywords struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other Structure summary 1 0 1996-12-23 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_related.content_type _pdbx_database_related.details _pdbx_database_status.process_site _struct_keywords.text _struct_ref_seq_dif.details representative structure Y BNL 1996-08-15 REL 0.1 ANGSTROM MAXIMUM DISTANCE VIOLATION 120 20 2D 1H-1H NOESY 5.0 283 K SIMULATED ANNEALING IN 4D MORIKAMI,NAKAI,KIDERA,SAITO,NAKAMURA refinement PRESTO structure solution EMBOSS 600.13 Bruker AMX-600 MET 140 n 1 MET 140 A GLU 141 n 2 GLU 141 A VAL 142 n 3 VAL 142 A LYS 143 n 4 LYS 143 A LYS 144 n 5 LYS 144 A THR 145 n 6 THR 145 A SER 146 n 7 SER 146 A TRP 147 n 8 TRP 147 A THR 148 n 9 THR 148 A GLU 149 n 10 GLU 149 A GLU 150 n 11 GLU 150 A GLU 151 n 12 GLU 151 A ASP 152 n 13 ASP 152 A ARG 153 n 14 ARG 153 A ILE 154 n 15 ILE 154 A LEU 155 n 16 LEU 155 A TYR 156 n 17 TYR 156 A GLN 157 n 18 GLN 157 A ALA 158 n 19 ALA 158 A HIS 159 n 20 HIS 159 A LYS 160 n 21 LYS 160 A ARG 161 n 22 ARG 161 A LEU 162 n 23 LEU 162 A GLY 163 n 24 GLY 163 A ASN 164 n 25 ASN 164 A ARG 165 n 26 ARG 165 A TRP 166 n 27 TRP 166 A ALA 167 n 28 ALA 167 A GLU 168 n 29 GLU 168 A ILE 169 n 30 ILE 169 A ALA 170 n 31 ALA 170 A LYS 171 n 32 LYS 171 A LEU 172 n 33 LEU 172 A LEU 173 n 34 LEU 173 A PRO 174 n 35 PRO 174 A GLY 175 n 36 GLY 175 A ARG 176 n 37 ARG 176 A THR 177 n 38 THR 177 A ASP 178 n 39 ASP 178 A ASN 179 n 40 ASN 179 A ALA 180 n 41 ALA 180 A ILE 181 n 42 ILE 181 A LYS 182 n 43 LYS 182 A ASN 183 n 44 ASN 183 A HIS 184 n 45 HIS 184 A TRP 185 n 46 TRP 185 A ASN 186 n 47 ASN 186 A SER 187 n 48 SER 187 A THR 188 n 49 THR 188 A MET 189 n 50 MET 189 A ARG 190 n 51 ARG 190 A ARG 191 n 52 ARG 191 A LYS 192 n 53 LYS 192 A VAL 193 n 54 VAL 193 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 12 A ARG 153 0.092 SIDE CHAIN 1 A GLU 141 -156.17 47.52 1 A LYS 143 69.57 -69.78 1 A ASN 164 -160.76 22.33 1 A LYS 192 67.03 90.39 2 A LYS 143 -177.90 -43.54 2 A ASN 164 -83.19 30.91 3 A VAL 142 36.95 -124.85 3 A LYS 143 28.75 59.97 3 A SER 146 73.25 119.09 3 A ASN 164 -160.57 22.30 3 A LYS 192 59.75 105.47 4 A LYS 143 -140.28 -23.77 4 A SER 146 -150.73 35.81 4 A ASN 164 -81.56 45.07 4 A ARG 165 -102.27 69.97 4 A THR 188 -104.99 -61.06 5 A VAL 142 -137.98 -41.81 5 A LYS 143 -164.22 102.60 5 A SER 146 -162.30 65.83 5 A ALA 167 -50.74 -71.66 5 A THR 188 -104.09 -69.84 6 A VAL 142 48.12 -177.13 6 A LYS 143 51.06 -160.51 6 A LYS 144 -91.06 32.50 6 A THR 188 -157.33 -39.36 6 A ARG 190 62.27 100.77 7 A GLU 141 62.36 92.41 7 A LYS 143 38.55 51.86 7 A ASN 164 -160.35 25.05 7 A ARG 176 57.32 -176.90 7 A THR 188 -79.24 -77.46 7 A LYS 192 56.54 82.91 8 A VAL 142 39.14 46.42 8 A LYS 143 39.75 41.18 8 A THR 188 -82.36 -70.67 9 A LYS 143 -84.02 -70.35 9 A LYS 144 -90.10 52.94 9 A ASN 164 -79.95 28.05 9 A SER 187 -79.29 -82.39 9 A MET 189 -172.78 -40.27 10 A GLU 141 66.76 -72.75 10 A VAL 142 62.98 175.92 10 A LYS 143 85.32 -31.43 10 A SER 146 -66.35 -75.37 10 A TRP 166 -77.39 35.93 10 A SER 187 -84.54 35.89 10 A THR 188 -160.38 -33.43 10 A ARG 191 63.62 -176.07 11 A THR 145 -66.20 88.83 11 A ASP 152 -124.38 -51.39 11 A ARG 165 -114.43 66.09 11 A THR 188 -137.78 -66.73 11 A MET 189 -66.99 -76.21 11 A ARG 191 71.47 175.01 11 A LYS 192 60.89 74.79 12 A LYS 143 -160.01 -49.82 12 A SER 146 -87.05 -154.95 12 A TRP 166 -74.79 37.75 12 A ALA 167 -91.14 -69.44 12 A ARG 191 70.12 -61.20 13 A THR 188 -105.81 -74.17 13 A ARG 191 -159.45 -67.81 13 A LYS 192 -173.28 -67.80 14 A GLU 141 48.71 74.68 14 A THR 145 -68.17 92.56 14 A ASN 164 -160.89 21.40 14 A SER 187 -90.44 -63.02 14 A MET 189 -81.43 46.96 14 A ARG 190 -179.97 60.84 15 A ASN 164 -160.49 23.79 15 A SER 187 -86.88 31.71 15 A THR 188 -156.04 -60.54 15 A LYS 192 79.57 -49.53 16 A GLU 141 74.35 -61.82 16 A VAL 142 -59.66 -73.62 16 A LYS 143 74.88 -48.12 16 A LYS 144 -59.42 103.58 16 A SER 146 77.23 151.89 16 A THR 188 -92.23 -61.40 16 A ARG 190 -101.72 57.08 16 A LYS 192 -103.89 45.64 17 A ARG 161 -90.69 -62.87 17 A ASN 164 -82.11 49.81 17 A ARG 165 -112.25 61.60 17 A ASN 186 -90.61 -60.71 17 A LYS 192 -140.78 -69.84 18 A SER 146 -68.29 91.10 18 A ALA 170 -80.61 42.65 18 A PRO 174 -69.32 82.57 18 A ARG 176 56.23 92.38 18 A THR 188 -110.23 61.98 18 A MET 189 -176.63 -42.57 18 A LYS 192 -142.00 -66.42 19 A THR 145 -84.88 35.44 19 A THR 188 -149.98 55.18 19 A MET 189 -171.34 49.85 19 A ARG 191 -52.14 108.98 20 A GLU 141 -111.50 -114.69 20 A SER 146 -80.22 36.41 20 A ASN 164 -161.27 21.52 20 A THR 188 -80.90 -94.26 20 A ARG 191 64.12 178.23 20 A LYS 192 73.56 -66.58 refinement AMBER STRUCTURE OF MYB TRANSFORMING PROTEIN, NMR, 20 STRUCTURES 1 Y N A GLU 149 A GLU 10 HELX_P A LEU 162 A LEU 23 1 1 14 A TRP 166 A TRP 27 HELX_P A LEU 172 A LEU 33 1 2 7 A ASP 178 A ASP 39 HELX_P A SER 187 A SER 48 1 3 10 DNA BINDING PROTEIN PROTOONCOGENE PRODUCT, DNA-BINDING PROTEIN, DNA BINDING PROTEIN MYB_MOUSE UNP 1 1 P06876 MARRPRHSIYSSDEDDEDIEMCDHDYDGLLPKSGKRHLGKTRWTREEDEKLKKLVEQNGTDDWKVIANYLPNRTDVQCQH RWQKVLNPELIKGPWTKEEDQRVIELVQKYGPKRWSVIAKHLKGRIGKQCRERWHNHLNPEVKKTSWTEEEDRIIYQAHK RLGNRWAEIAKLLPGRTDNAIKNHWNSTMRRKVEQEGYLQEPSKASQTPVATSFQKNNHLMGFGHASPPSQLSPSGQSSV NSEYPYYHIAEAQNISSHVPYPVALHVNIVNVPQPAAAAIQRHYNDEDPEKEKRIKELELLLMSTENELKGQQALPTQNH TCSYPGWHSTSIVDQTRPHGDSAPVSCLGEHHATPSLPADPGSLPEESASPARCMIVHQGTILDNVKNLLEFAETLQFID SFLNTSSNHESSGLDAPTLPSTPLIGHKLTPCRDQTVKTQKENSIFRTPAIKRSILESSPRTPTPFKHALAAQEIKYGPL KMLPQTPSHAVEDLQDVIKRESDESGIVAEFQESGPPLLKKIKQEVESPTEKSGNFFCSNHWAENSLSTQLFSQASPVAD APNILTSSVLMTPVSEDEDNVLKAFTVPKNRPLVGPLQPCSGAWEPASCGKTEDQMTASGPARKYVNAFSARTLVM 141 193 1IDZ 141 193 P06876 A 1 2 54 1 ILE engineered mutation LEU 155 1IDZ A P06876 UNP 155 16 1 P 1